Cumberland Pharmaceuticals Inc.
CPIX
$5.72
-$0.14-2.39%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -125.33% | 56.23% | 69.38% | 71.75% | 61.08% |
| Total Depreciation and Amortization | -6.64% | -12.53% | 2.14% | 1.98% | 2.52% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 123.26% | 121.76% | -109.81% | -144.92% | -127.30% |
| Change in Net Operating Assets | -20.52% | 67.24% | 161.45% | 165.40% | -9.39% |
| Cash from Operations | -73.80% | 905.70% | 562.80% | 1,095.17% | 0.88% |
| Capital Expenditure | 30.62% | -47.22% | 11.25% | 39.04% | 66.37% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -235.59% | -3,807.56% | -440.47% | -425.62% | -559.64% |
| Cash from Investing | -218.23% | -8,242.56% | -580.85% | -1,388.43% | -10,692.38% |
| Total Debt Issued | -- | -- | -86.48% | -56.00% | -20.26% |
| Total Debt Repaid | 100.00% | 72.12% | 56.42% | 20.83% | -11.23% |
| Issuance of Common Stock | -100.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | 86.38% | 54.49% | 45.95% | 41.71% | 27.94% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -19.26% | 0.19% | 37.96% | 35.88% | 34.42% |
| Cash from Financing | 74.42% | -3,525.85% | -8,537.87% | -2,847.24% | -140.44% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -19.21% | -1,724.15% | -117.43% | -36.90% | -259.09% |